Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dry Needling vs Botulinum Toxin in Bruxism
NCT07452510Completed
- Sponsor
- Recep Tayyip Erdoğan University
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in bruxism (3 arms), sponsored by Recep Tayyip Erdoğan University. Primary endpoints: Visual Analog Scale at 3 months and Masseter and Anterior Temporal Muscle Thickness at 3 months. Started Jan 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT07452510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07452510.